Beth Ashbridge, Ph.D.

CuraTeQ Biologics' Trastuzumab Biosimilar Receives Positive Opinion In Europe

Health Headlines: March 2025

Celltrion Wins Costco Formulary Listing For Its Recently Launched Ustekinumab

The 43rd Annual J.P. Morgan Healthcare Conference Starts Today – A Who's Who In Biologics At This Year's Conference

Recent Biologics Deals

Alvotech Requests That FDA Refuse To License CHO-Cell Derived Ustekinumab Biosimilars As Interchangeable Until The Effects Of Sialylation Are Evaluated

FTC Comment On FDA Draft Guidance On Interchangeability

Acuitas File Complaint Against Alnylam For Declaratory Judgment Of Co-Inventorship Of Lipid Particle Patents

FDA Approves Boehringer Ingelheim's CYLTEZO® Biosimilar To Humira For Multiple Chronic Inflammatory Diseases

FDA Approves BMS And J&J CAR-T Cell Therapies For The Earlier Treatment Of Multiple Myeloma